164 related articles for article (PubMed ID: 37448256)
41. VV-ECMO combined with prone position ventilation in the treatment of Pneumocystis jirovecii pneumonia: A case report.
Jia L; Zhang Z; Bai Y; Du Q
Medicine (Baltimore); 2022 Jan; 101(1):e28482. PubMed ID: 35029898
[TBL] [Abstract][Full Text] [Related]
42. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
Kato H; Samukawa S; Takahashi H; Nakajima H
J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
[TBL] [Abstract][Full Text] [Related]
44. Extrapulmonary Pneumocystis jirovecii infection in an advanced HIV-infected patient: A case report and literature review.
Tancharoen L; Muangsomboon S; Sarasombath PT; Angkasekwinai N
BMC Infect Dis; 2023 Mar; 23(1):185. PubMed ID: 36991362
[TBL] [Abstract][Full Text] [Related]
45. Pneumocystis jirovecii Pneumonia Secondary to Blinatumomab Therapy: A Case Report.
Yin Y; Shen K; Li H; Zhang L
Chemotherapy; 2024; 69(2):104-107. PubMed ID: 38508148
[TBL] [Abstract][Full Text] [Related]
46. How to diagnose and treat a patient without human immunodeficiency virus infection having Pneumocystis jirovecii pneumonia?
Hänsel L; Schumacher J; Denis B; Hamane S; Cornely OA; Koehler P
Clin Microbiol Infect; 2023 Aug; 29(8):1015-1023. PubMed ID: 37086781
[TBL] [Abstract][Full Text] [Related]
47.
Springsted E; Giri B; Kollipara V
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34162609
[TBL] [Abstract][Full Text] [Related]
48. Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis.
Andreasen PB; Rezahosseini O; Møller DL; Wareham NE; Thomsen MT; Houmami R; Knudsen AD; Knudsen J; Kurtzhals JAL; Rostved AA; Pedersen CR; Rasmussen A; Nielsen SD
Immun Inflamm Dis; 2022 Jan; 10(1):93-100. PubMed ID: 34713963
[TBL] [Abstract][Full Text] [Related]
49. Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation.
Trubin PA; Azar MM
Infect Dis Clin North Am; 2023 Sep; 37(3):617-640. PubMed ID: 37142510
[TBL] [Abstract][Full Text] [Related]
50. A heart transplant recipient lost due to Pneumocystis jiroveci pneumonia under trimethoprim-sulfamethoxazole prophylaxis: case report.
Celik T; Gedik E; Kayabas U; Bayindir Y; Gulbas G; Firat AK; Togal T
Exp Clin Transplant; 2010 Dec; 8(4):325-8. PubMed ID: 21143101
[TBL] [Abstract][Full Text] [Related]
51. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
52. Clinical characteristics and risk factors for late-onset pneumocystis jirovecii pneumonia in kidney transplantation recipients.
Zhu X; Xie M; Fan J; Geng B; Fei G; Zhou Q; Wu H; Liu X; Jiang X
Mycoses; 2024 Jan; 67(1):e13688. PubMed ID: 38214337
[TBL] [Abstract][Full Text] [Related]
53. Fatal Pneumocystis jirovecii pneumonia in a HIV-negative adult.
Haddad TM; Vallabhajosyula S; Nawaz MS; Vivekanandan R
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26311008
[TBL] [Abstract][Full Text] [Related]
54. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
55. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for
Awad M; Sierra CM; Mesghali E; Bahjri K
J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970
[TBL] [Abstract][Full Text] [Related]
56. Pneumocystis jirovecii pneumonia in liver transplant recipients: a systematic review.
Kostakis ID; Sotiropoulos GC; Kouraklis G
Transplant Proc; 2014 Nov; 46(9):3206-8. PubMed ID: 25420860
[TBL] [Abstract][Full Text] [Related]
57. Round opacity as a presentation of pneumocystis jirovecii pneumonia in an HIV-infected patient.
Jiménez-Castillo RA; Fernández LT; Vera-Pineda R; Carrizales-Sepúlveda EF; García-Arellano G; González-Aguirre JE
Am J Emerg Med; 2019 Jan; 37(1):176.e3-176.e4. PubMed ID: 30287130
[TBL] [Abstract][Full Text] [Related]
58. A rare cause of cavitary lung lesions.
Pierre-Louis N; Dlugos B
JAAPA; 2017 Jan; 30(1):28-31. PubMed ID: 28033170
[TBL] [Abstract][Full Text] [Related]
59. Pneumocystis jirovecii pneumonia in kidney transplantation.
Goto N; Oka S
Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
[TBL] [Abstract][Full Text] [Related]
60. Usefulness of beta-D glucan in diagnosing Pneumocystis carinii pneumonia and monitoring its treatment in a living-donor liver-transplant recipient.
Kawagishi N; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Satomi S
J Hepatobiliary Pancreat Surg; 2007; 14(3):308-11. PubMed ID: 17520208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
